Post-Stroke Spasticity Treatment: A Retrospective Cohort Study From Alberta, Canada
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · 2024
DOI: 10.1017/cjn.2024.342 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques, 2024. Verfasst von Lalith Satkunam und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: Muscle Spasticity, Stroke, Muscle Relaxants, Central. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Understanding post-stroke spasticity (PSS) treatment in everyday clinical practice may guide improvements in patient care.
Methods
This was a retrospective cohort study that used population-level administrative data. Adults (aged ≥18 years) who initiated PSS treatment (defined by the first PSS clinic visit, focal botulinum toxin injection, or anti-spasticity medication dispensation [baclofen, dantrolene and tizanidine] with none of these treatments occurring during the 2 years before the stroke) were identified between 2012 and 2019 in Alberta, Canada. Spasticity treatment use, time to treatment start and type of prescribing/treating physician were measured. Descriptive statistics were performed.
Results
Within the cohort (n = 1,079), the most common PSS treatment was oral baclofen (initial treatment: 60.9%; received on/after the initial treatment date up to March 31, 2020: 69.0%), largely prescribed by primary care physicians (77.6%) and started a median of 348 (IQR 741) days after the stroke. Focal botulinum toxin (23.3%; 37.7%) was largely prescribed by physiatrists (72.2%) and started 311 (IQR 446) days after the stroke; spasticity clinic visits (18.6%; 23.8%) were also common.
Conclusions
We found evidence of gaps in provision of spasticity management in persons with PSS including overuse of systemic oral baclofen (that has common adverse side effects and lacks evidence of effectiveness in PSS) and potential underuse of focal botulinum toxin injections. Further investigation and strategies should be pursued to improve alignment of PSS treatment with guideline recommendations that in turn will support better outcomes for those with PSS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.
- Division of Adult Rehabilitation, Glenrose Rehabilitation Hospital, Edmonton, Alberta, Canada.
- Cumming School of Medicine, Hotchkiss Brain Institute, Department of Clinical Neurosciences, University of Calgary, Calgary, Alberta, Canada.
- Real World Evidence Unit, University of Alberta, Edmonton, Alberta, Canada.
- Centre for Health Informatics, University of Calgary, Calgary, Alberta, Canada.
- College of Health Sciences, University of Alberta, Edmonton, Alberta, Canada.
ORCID-Profile: Jaime C Yu, Karen J B Martins
Zitieren
APA
Satkunam, L., Dukelow, S. P., Yu, J. C., McNeil, S., Luu, H., Martins, K. J. B., Vu, K., Nguyen, P. U., Richer, L., Williamson, T., & Klarenbach, S. W. (2024). Post-Stroke Spasticity Treatment: A Retrospective Cohort Study From Alberta, Canada. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. https://doi.org/10.1017/cjn.2024.342
Vancouver
Satkunam L, Dukelow SP, Yu JC, McNeil S, Luu H, Martins KJB, et al. Post-Stroke Spasticity Treatment: A Retrospective Cohort Study From Alberta, Canada. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 2024. doi:10.1017/cjn.2024.342
BibTeX
@article{Satkunam2024,
author = {Satkunam, Lalith and Dukelow, Sean P and Yu, Jaime C and McNeil, Stephen and Luu, Huong and Martins, Karen J B and Vu, Khanh and Nguyen, Phuong Uyen and Richer, Lawrence and Williamson, Tyler and Klarenbach, Scott W},
title = {Post-Stroke Spasticity Treatment: A Retrospective Cohort Study From Alberta, Canada},
journal = {Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques},
year = {2024},
doi = {10.1017/cjn.2024.342}
}
EUVIMED